Eli Lilly gains following breakthrough therapy designation for its investigational antibody therapy for Alzheimer's Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Eli Lilly (LLY) up 7% after the FDA granted breakthrough therapy designation for donanemab, the company's investigational antibody therapy for Alzheimer's disease
- Palantir (PLTR) up 1% after the company and DataRobot announced a new partnership designed to create solutions to help solve forecasting problems
- MGM Resorts (MGM) up 2% after Deutsche Bank analyst Carlo Santarelli upgraded shares to Buy from Hold with a price target of $54, up from $42
- Marin Software (MRIN) up 80% after announcing the ability to manage Instacart Ads to its flagship MarinOne platform
UP AFTER EARNINGS -
- Accenture (ACN) up 4%
- Darden (DRI) up 1%
DOWN AFTER EARNINGS -
- Rite Aid (RAD) down 11%
- KB Home (KBH) down 4%
LOWER -
- Biogen (BIIB) down 6% after Eli Lilly's breakthrough therapy designation for Alzheimer's antibody therapy donanemab
- Portage Biotech (PRTG) down 28% after equity offering of undisclosed amount
Symbols:
LLY PLTR MGM MRIN ACN DRI RAD KBH BIIB PRTG Keywords: Fly Intel, Wall Street, Top Stories, Stocks